 | Up a level |
Moor, Jeanne; Kuhne, Michael; Moschovitis, Giorgio; Kobza, Richard; Netzer, Seraina; Auricchio, Angelo; Beer, Juerg H; Bonati, Leo; Reichlin, Tobias; Conen, David; Osswald, Stefan; Rodondi, Nicolas; Clair, Carole; Baumgartner, Christine; Aubert, Carole Elodie (2024). Sex-specific association of cardiovascular drug doses with adverse outcomes in atrial fibrillation. Open Heart, 11(2) B M J Group 10.1136/openhrt-2024-002720
Jungo, Katharina Tabea; Deml, Michael J; Schalbetter, Fabian; Moor, Jeanne; Feller, Martin; Vidonscky Lüthold, Renata; Huibers, Corlina Johanna Alida; Sallevelt, Bastiaan Theodoor Gerard Marie; Meulendijk, Michiel C; Spruit, Marco; Schwenkglenks, Matthias; Rodondi, Nicolas; Streit, Sven (2024). Correction: A mixed methods analysis of the medication review intervention centered around the use of the 'Systematic Tool to Reduce Inappropriate Prescribing' Assistant (STRIPA) in Swiss primary care practices. BMC health services research, 24(413) BioMed Central 10.1186/s12913-024-10896-2
Jungo, Katharina Tabea; Deml, Michael J; Schalbetter, Fabian; Moor, Jeanne; Feller, Martin; Vidonscky Lüthold, Renata; Huibers, Johanna Alida Corlina; Sallevelt, Bastiaan Theodoor Gerard Marie; Meulendijk, Michiel C; Spruit, Marco; Schwenkglenks, Matthias; Rodondi, Nicolas; Streit, Sven (2024). A mixed methods analysis of the medication review intervention centered around the use of the 'Systematic Tool to Reduce Inappropriate Prescribing' Assistant (STRIPA) in Swiss primary care practices. BMC health services research, 24(1), p. 350. BioMed Central 10.1186/s12913-024-10773-y
Darphin, Xenia; Moor, Jeanne; da Silva, Cristina Espinosa; Richters, Anke; Özdemir, Berna C (2024). Awareness of the impact of sex and gender in the disease risk and outcomes in hematology and medical oncology-a survey of Swiss clinicians. Cancer reports, 7(2), e1961. Wiley 10.1002/cnr2.1961
Strumann, Christoph; Ranzani, Otavio T; Moor, Jeanne; Berner, Reinhard; Toepfner, Nicole; Chao, Cho-Ming; Moor, Matthias B (2023). Effectiveness of BNT162b2 mRNA Covid-19 vaccine in children under 5 years. Journal of clinical investigation, 133(21), e173329. American Society for Clinical Investigation 10.1172/JCI173329
Toepfner, Nicole; von Meißner, Wolfgang C G; Strumann, Christoph; Drinka, Denisa; Stuppe, David; Jorczyk, Maximilian; Moor, Jeanne; Püschel, Johannes; Liss, Melanie; von Poblotzki, Emilie; Berner, Reinhard; Moor, Matthias B; Chao, Cho-Ming (2022). Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years. JAMA Network Open, 5(10), e2237140. American Medical Association 10.1001/jamanetworkopen.2022.37140
Moor, Jeanne; Baumgartner, Christine; Méan, Marie; Stalder, Odile; Limacher, Andreas; Rodondi, Nicolas; Aujesky, Drahomir (2021). Validation of the 2019 European Society of Cardiology risk stratification algorithm for pulmonary embolism in normotensive elderly patients. Thrombosis and haemostasis, 121(12), pp. 1660-1667. Thieme 10.1055/a-1475-2263
Baumgartner, Christine; Klok, Frederikus A; Carrier, Marc; Limacher, Andreas; Moor, Jeanne; Righini, Marc; Beer, Jürg-Hans; Peluso, Martina; Rakovic, Damiana; Huisman, Menno V; Aujesky, Drahomir (2020). Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: protocol for a multicentre randomised placebo-controlled non-inferiority trial (SAFE-SSPE). BMJ open, 10(11), e040151. BMJ Publishing Group 10.1136/bmjopen-2020-040151
